The c-Abl proto-oncoprotein is a member of the Src family of non-receptor tyrosine kinases. The highly evolutionarily conserved c-Abl was identified as the cellular homologue of the Ablelson murine ...

Further development of second generation Abl tyrosine kinase inhibitors like nilotinib and dasatinib improved CML therapy, 6, 7, 8, 9, 10, 11, 12 but the persistence ...

Rocket builder ABL Space closed a $170 million round of funding with a $1.3 billion valuation, making it the latest private space venture to reach unicorn status. ABL raised the funds from T. Rowe ...

An asset based loan (“ABL”) is often the financing of choice for retail borrowers – and for good reason. In its simplest form, an ABL is a credit facility, usually in the form of a revolving line of ...

ABL Bio said on the 12th that it signed a technology transfer and joint research and development agreement with U.S.-based Eli Lilly for the "Grabody-B" platform, a technology that penetrates the ...

(RTTNews) - ABL Bio Inc. said that it has entered into collaboration and worldwide license agreement with Sanofi (SNYNF, SNY) to develop and commercialize ABL301, a pre-clinical stage bispecific ...

Arch Capital Management (“Arch”), a new working capital and asset-based lending platform, today announced its official launch, expanding the team’s commitment to helping growth-oriented businesses ...

A California company that has yet to even attempt a rocket launch has nonetheless inked a major deal with Lockheed Martin for dozens of missions over the next decade. Under terms of the block-buy ...

Lockheed Martin said it selected rocket-builder ABL Space to launch a mission with an RS1 rocket from Scotland in 2022. The companies hope this would be the first satellite launch from the U.K. and ...

The contemplated transaction remains subject to due diligence, definitive agreements, regulatory approvals and Nasdaq listing requirements; no change to ABL S.A.’s control over ABL Diagnostics at this ...